Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
50
CBFV Quote, Financials, Valuation and Earnings
Last price:
$29.30
Seasonality move
:
1.6%
Day range:
$29.07 - $29.52
52-week range:
$20.75 - $33.72
Dividend yield:
3.41%
P/E ratio:
6.58x
P/S ratio:
3.88x
P/B ratio:
1.01x
Volume:
8.3K
Avg. volume:
7K
1-year change:
21.93%
Market cap:
$150.1M
Revenue:
$42.4M
EPS (TTM):
$4.45
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $49.8M | $48.9M | $46.7M | $50M | $42.4M | |
| Revenue Growth (YoY) | 11.19% | -1.85% | -4.65% | 7.1% | -15.22% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.3M | $23.4M | $21.9M | $19.9M | $23.4M | |
| Other Inc / (Exp) | $140K | $233K | $5.7M | -$168K | $14.4M | |
| Operating Expenses | $24.4M | $5.6M | $25.6M | $22.1M | $49.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $16.1M | -$9.4M | $14.7M | $14.1M | $30.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.7M | $1.2M | $3.1M | $2.8M | $7.7M | |
| Net Income to Company | $14.3M | -$10.6M | $11.6M | $11.2M | $22.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.3M | -$10.6M | $11.6M | $11.2M | $22.6M | |
| Basic EPS (Cont. Ops) | $2.64 | -$1.97 | $2.15 | $2.19 | $4.41 | |
| Diluted EPS (Cont. Ops) | $2.63 | -$1.97 | $2.15 | $2.18 | $4.40 | |
| Weighted Average Basic Share | $5.4M | $5.4M | $5.4M | $5.1M | $5.1M | |
| Weighted Average Diluted Share | $5.4M | $5.4M | $5.4M | $5.1M | $5.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $23.9M | -$3.8M | $18.1M | $18.9M | $48M | |
| Revenue (Reported) | $49.8M | $48.9M | $46.7M | $50M | $42.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $23.9M | -$3.8M | $18.1M | $18.9M | $48M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.9M | $10.6M | $12.8M | $12.8M | $12.1M | |
| Revenue Growth (YoY) | -5.12% | -10.86% | 20.09% | 0.56% | -5.49% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $5.9M | $5.1M | $5.7M | $4.9M | |
| Other Inc / (Exp) | -$59K | $24K | -$46K | -$37K | $383K | |
| Operating Expenses | -$13.1M | $6.3M | $6M | $6.1M | $5.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$17.6M | $2.4M | $4.9M | $3.2M | $4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$184K | $452K | $998K | $564K | $747K | |
| Net Income to Company | -$17.4M | $2M | $3.9M | $2.7M | $3.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$17.4M | $2M | $3.9M | $2.7M | $3.2M | |
| Basic EPS (Cont. Ops) | -$3.22 | $0.37 | $0.77 | $0.52 | $0.63 | |
| Diluted EPS (Cont. Ops) | -$3.22 | $0.37 | $0.77 | $0.52 | $0.60 | |
| Weighted Average Basic Share | $5.4M | $5.4M | $5.1M | $5.1M | $5.1M | |
| Weighted Average Diluted Share | $5.4M | $5.4M | $5.1M | $5.1M | $5.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$16.3M | $3.2M | $6.2M | $8.4M | $12.3M | |
| Revenue (Reported) | $11.9M | $10.6M | $12.8M | $12.8M | $12.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$16.3M | $3.2M | $6.2M | $8.4M | $12.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $48.8M | $47.2M | $48.7M | $53.7M | $39.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23M | $24.1M | $18.9M | $21.5M | $21.3M | |
| Other Inc / (Exp) | $106K | $695K | -$208K | -$285K | $14.9M | |
| Operating Expenses | $5.5M | $22.4M | $26.3M | $23.3M | $47.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$9M | $9.5M | $17.7M | $17.2M | $30.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $23K | $1.8M | $3.7M | $3.5M | $7.6M | |
| Net Income to Company | -$9M | $7.7M | $14.1M | $13.7M | $23M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9M | $7.7M | $14.1M | $13.7M | $23M | |
| Basic EPS (Cont. Ops) | -$1.68 | $1.42 | $2.70 | $2.68 | $4.50 | |
| Diluted EPS (Cont. Ops) | -$1.69 | $1.42 | $2.68 | $2.68 | $4.45 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$2.5M | $13.3M | $21.2M | $31.1M | $58.5M | |
| Revenue (Reported) | $48.8M | $47.2M | $48.7M | $53.7M | $39.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$2.5M | $13.3M | $21.2M | $31.1M | $58.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $36M | $34.2M | $36.3M | $40M | $36.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.2M | $17.9M | $14.9M | $16.5M | $14.4M | |
| Other Inc / (Exp) | $20K | $482K | -$252K | -$369K | $186K | |
| Operating Expenses | -$827K | $16M | $16.7M | $17.9M | $15.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$13.1M | $5.8M | $8.9M | $12M | $12.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $640K | $1.2M | $1.8M | $2.4M | $2.2M | |
| Net Income to Company | -$13.7M | $4.6M | $7.1M | $9.6M | $10.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.7M | $4.6M | $7.1M | $9.6M | $10.1M | |
| Basic EPS (Cont. Ops) | -$2.54 | $0.85 | $1.38 | $1.87 | $1.97 | |
| Diluted EPS (Cont. Ops) | -$2.54 | $0.85 | $1.37 | $1.87 | $1.93 | |
| Weighted Average Basic Share | $16.2M | $16.2M | $15.5M | $15.3M | $15.4M | |
| Weighted Average Diluted Share | $16.2M | $16.3M | $15.5M | $15.4M | $15.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$8.6M | $8.5M | $11.6M | $23.9M | $34.5M | |
| Revenue (Reported) | $36M | $34.2M | $36.3M | $40M | $36.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$8.6M | $8.5M | $11.6M | $23.9M | $34.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $80.2M | $160.9M | $119.7M | $103.7M | $68.2M | |
| Short Term Investments | $194.7M | $142.9M | $222.1M | $187.4M | $204.5M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $274.9M | $303.8M | $341.8M | $291.1M | $272.7M | |
| Property Plant And Equipment | $22.3M | $20.3M | $18.4M | $17.8M | $19.7M | |
| Long-Term Investments | $197.4M | $145.4M | $225M | $190.1M | $207.1M | |
| Goodwill | $28.4M | $9.7M | $9.7M | $9.7M | $9.7M | |
| Other Intangibles | $10.5M | $8.4M | $5.3M | $3.5M | $958K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.3B | $1.4B | $1.4B | $1.4B | $1.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $6M | $2M | $3M | -- | $20M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $36.6M | $43.1M | $42.3M | $8.1M | $20M | |
| Long-Term Debt | $8M | $6M | $14.6M | $14.6M | $14.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Common Stock | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $151.1M | $134.5M | $133.1M | $110.2M | $139.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $151.1M | $134.5M | $133.1M | $110.2M | $139.8M | |
| Total Liabilities and Equity | $1.3B | $1.4B | $1.4B | $1.4B | $1.5B | |
| Cash and Short Terms | $274.9M | $303.8M | $341.8M | $291.1M | $272.7M | |
| Total Debt | $14M | $8M | $17.6M | $14.6M | $34.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $112.2M | $173.5M | $122.8M | $52.6M | $147.3M | |
| Short Term Investments | $159M | $218.5M | $191.2M | $170.6M | $268.2M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $271.1M | $392.1M | $314M | $223.2M | $415.6M | |
| Property Plant And Equipment | $20.4M | $18.5M | $18.1M | $18.5M | $20.8M | |
| Long-Term Investments | $159M | $221.4M | $193.8M | $172.9M | $270.9M | |
| Goodwill | $9.7M | $9.7M | $9.7M | $9.7M | $9.7M | |
| Other Intangibles | $8.9M | $5.7M | $4M | $2.2M | $88K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.4B | $1.5B | $1.4B | $1.4B | $1.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $5M | $3M | $3M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $47.1M | $45.6M | $21.1M | -- | -- | |
| Long-Term Debt | $6M | $3M | $14.6M | $34.7M | $34.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.3B | $1.3B | $1.3B | $1.4B | |
| Common Stock | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $133.3M | $131M | $106.7M | $114.8M | $149.1M | |
| Total Liabilities and Equity | $1.4B | $1.5B | $1.4B | $1.4B | $1.6B | |
| Cash and Short Terms | $271.1M | $392.1M | $314M | $223.2M | $415.6M | |
| Total Debt | $11M | $6M | $17.6M | $34.7M | $34.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.3M | -$10.6M | $11.6M | $11.2M | $22.6M | |
| Depreciation & Amoritzation | $3.7M | $3.3M | $2.4M | $2.7M | $2.7M | |
| Stock-Based Compensation | $323K | $498K | $566K | $600K | $1.1M | |
| Change in Accounts Receivable | $139K | -$575K | $522K | -$633K | -$1.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.9M | $14.1M | $13.1M | $14.2M | $14.2M | |
| Capital Expenditures | $948K | $322K | $2.4M | $509K | $3.3M | |
| Cash Acquisitions | -- | -- | -- | -- | $26.9M | |
| Cash From Investing | -$11M | -$36.9M | -$60.1M | -$28.3M | -$54.7M | |
| Dividends Paid (Ex Special Dividend) | -$5.2M | -$5.2M | -$5.2M | -$4.9M | -$5.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $14.6M | -- | $20M | |
| Long-Term Debt Repaid | -$6M | -$6M | -$5M | -$3M | -- | |
| Repurchase of Common Stock | -$71K | -$1.9M | -$4.1M | -$4.8M | -$843K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $20M | $103.5M | $5.8M | -$1.8M | $5M | |
| Beginning Cash (CF) | $53.4M | $80.2M | $160.9M | $119.7M | $103.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $26.9M | $80.7M | -$41.2M | -$16M | -$35.5M | |
| Ending Cash (CF) | $80.2M | $160.9M | $119.7M | $103.7M | $68.2M | |
| Levered Free Cash Flow | $16.9M | $13.8M | $10.7M | $13.6M | $10.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$17.4M | $2M | $3.9M | $2.7M | $3.2M | |
| Depreciation & Amoritzation | $420K | $554K | $715K | $713K | $573K | |
| Stock-Based Compensation | $114K | $169K | $145K | $196K | $215K | |
| Change in Accounts Receivable | $422K | $251K | -$95K | -$39K | -$592K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.5M | $550K | $3.8M | $9.1M | $3.1M | |
| Capital Expenditures | $87K | $35K | $208K | $249K | $856K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$25.3M | -$11.2M | -$6.8M | -$6.3M | -$778K | |
| Dividends Paid (Ex Special Dividend) | -$1.3M | -$1.3M | -$1.2M | -$1.3M | -$1.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$288K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | $7.1M | -- | -- | |
| Repurchase of Common Stock | -- | -$1.9M | -$694K | -- | -$326K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.5M | $12.1M | $44.7M | -$28.3M | $2.4M | |
| Beginning Cash (CF) | $131.4M | $172M | $81.1M | $78.1M | $142.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$19.2M | $1.5M | $41.7M | -$25.5M | $4.7M | |
| Ending Cash (CF) | $112.2M | $173.5M | $122.8M | $52.6M | $147.3M | |
| Levered Free Cash Flow | $2.4M | $515K | $3.6M | $8.9M | $2.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9M | $7.7M | $14.1M | $13.7M | $23M | |
| Depreciation & Amoritzation | $3.6M | $2.6M | $2.6M | $2.8M | $2.6M | |
| Stock-Based Compensation | $463K | $543K | $575K | $733K | $1.2M | |
| Change in Accounts Receivable | -$838K | $886K | -$54K | -$1.2M | -$1.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14.4M | $7.5M | $19.5M | $22.8M | $1.7M | |
| Capital Expenditures | $166K | $2.4M | $580K | $1.6M | $4.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$63.4M | -$22.8M | -$39.4M | -$46.9M | -$18.9M | |
| Dividends Paid (Ex Special Dividend) | -$5.2M | -$5.2M | -$5M | -$5.1M | -$5.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$6M | -$5M | -- | -- | -- | |
| Repurchase of Common Stock | -$2M | -$2.5M | -$6.4M | -$447K | -$847K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $72.8M | $76.7M | -$30.8M | -$46.1M | $111.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $23.8M | $61.4M | -$50.7M | -$70.2M | $94.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $14.2M | $5M | $18.9M | $21.1M | -$3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.7M | $4.6M | $7.1M | $9.6M | $10.1M | |
| Depreciation & Amoritzation | $2.6M | $1.8M | $2M | $2.1M | $2M | |
| Stock-Based Compensation | $370K | $415K | $424K | $557K | $591K | |
| Change in Accounts Receivable | -$944K | $517K | -$59K | -$600K | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.2M | $2.6M | $9.1M | $17.7M | $5.2M | |
| Capital Expenditures | $184K | $2.3M | $470K | $1.6M | $3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$60.5M | -$46.5M | -$25.8M | -$44.4M | -$8.5M | |
| Dividends Paid (Ex Special Dividend) | -$3.9M | -$3.9M | -$3.7M | -$3.8M | -$3.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $11.5M | -- | -- | $20M | -- | |
| Long-Term Debt Repaid | -$3M | -$2M | -- | -$8.1M | -- | |
| Repurchase of Common Stock | -$1.9M | -$2.5M | -$4.7M | -$327K | -$331K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $83.3M | $56.5M | $19.8M | -$24.4M | $82.5M | |
| Beginning Cash (CF) | $289.7M | $562.9M | $324.4M | $285.3M | $284.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $32M | $12.6M | $3.1M | -$51.1M | $79.1M | |
| Ending Cash (CF) | $321.7M | $575.5M | $327.5M | $234.2M | $363.6M | |
| Levered Free Cash Flow | $9M | $303K | $8.6M | $16.1M | $2.1M | |
Get CBFV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CBFV
Sector
P/E ratio
6.58x
11.99x
PEG ratio
0.10x
0.36x
P/B ratio
1.01x
1.05x
Price / LTM sales
3.88x
2.55x
Growth Metrics
CBFV
Sector
Revenue growth
-5.49%
6.08%
Earnings growth
15.39%
6.45%
Revenue (5-year growth)
-1.13%
5.85%
Earnings forecast
$0.51
$0.56
Profitability
CBFV
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
13.36%
5.27%
Return on assets
1.55%
0.98%
Return on equity
16.73%
9.43%
Earnings Date
Last Earnings Date
Oct
25
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
24
Balance Sheet
CBFV
Sector
Total cash
$415.6M
$615.3M
Short term investments
$204.5M
$408.4M
Total assets
$1.5B
$4.5B
Long term debt
$34.7M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
